INFINITY BIOLOGIX LLC - DNA EXTRACTION AND GENOTYPING OF CELL LINES FOR THE IPSC NEURODEGENERATION INITIATIVE PROJECT-PERIOD OF PERFORMANCE: JUNE 1, 2021-MARCH 1, 2022
Key Details
Description
DNA EXTRACTION AND GENOTYPING OF CELL LINES FOR THE IPSC NEURODEGENERATION INITIATIVE PROJECT-PERIOD OF PERFORMANCE: JUNE 1, 2021-MARCH 1, 2022
Context & Analysis
On May 19, 2021, Department of Health and Human Services to INFINITY BIOLOGIX LLC for dna extraction and genotyping of cell lines for the ipsc neurodegeneration initiative project-period of performance: june 1, 2021-march 1, 2022. The award is classified under NAICS 541380 — TESTING LABORATORIES AND SERVICES. Competition extent: not competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in PISCATAWAY, NJ. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541380 — related awards are listed below.
Contractor Information
Similar Awards
TRAVELER-BASED GENOMIC SURVEILLANCE PROGRAM
GINKGO BIOWORKS, INC.
$78.0M
WASTEWATER SURVEILLANCE TESTING
VERILY HEALTH INC.
$42.3M
INNOVATION FUNNEL FOR COVID-19 - VALIDATION CENTER
EMORY UNIVERSITY
$41.2M
STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
$38.8M
CENTRALIZED OMICS RESOURCE (CORE) YEAR 5
THE BROAD INSTITUTE, INC
$36.4M
Stay Updated
Get notified about new opportunities matching your interests.